GFI #256: How it affects compounding for veterinary patients – 2023 / 0.5 CE
This webinar will help veterinary compounders understand the requirements of GFI-256 and why such a document is necessary in the current federal landscape. Pharmacists and technicians will learn when FDA intends to use enforcement discretion regarding the compounding of animal drugs using bulk drug substances and how to comply with these requirements. They will also learn how they can nominate drugs to the list for compounding office stock drugs used for nonfood-producing animals.
Understanding the revision to USP <795> Pharmaceutical Compounding – Nonsterile Preparations – 2023 / 0.5 CE
This webinar will help pharmacists and technicians understand and prepare for changes to USP <795> Pharmaceutical Compounding – Nonsterile Preparations that will go into effect on November 1, 2023. The webinar will include differentiating dosage forms that may be compounded as nonsterile preparations and how to assign beyond-use dates as well as reviewing changes to facility, personnel, and documentation requirements.
Preparing for change: Key aspects of revised USP <797> Pharmaceutical Compounding – Sterile Preparations / 1 CE
This webinar will help pharmacists and technicians understand and prepare for changes to USP <797> Pharmaceutical Compounding – Sterile Preparations that will take effect on November 1, 2023. The webinar will include an overview of requirements including the transition to Category 1, Category 2, and Category 3 compounded sterile preparations and what each of these entails. Topics covered include requirements for facility and equipment, environmental monitoring, personnel training, and competency, documentation, and quality management.
Interpreting and Applying USP Compounded Preparation Monographs in Pharmacy Practice: Recipes for Quality / 1 CE
Since 1820, USP has published Compounded Preparation Monographs (CPMs) with the goal of standardizing quality-assured formulas for the most commonly used compounded preparations for humans and animals. While most pharmacy professionals are aware of these monographs, many do not understand the significance and utility of each of the sections of a monograph. Join this webinar to learn where to find and how to interpret the meaning and intent of these unique “recipes” and how to apply them to your veterinary pharmacy practice.
Gigi Davidson, RPh, DICVP, FACVP, FSVHP is the former Director of Clinical Pharmacy at the NC State University College of Veterinary Medicine where she practiced veterinary pharmacy for 35 years. Ms. Davidson received a pharmacy degree from UNC-Chapel Hill in 1983 and earned Diplomate status in the International College of Veterinary Pharmacy in 2001. She was inducted into the Phi Zeta Honor Society in 2006 as an honorary member for distinguished advancement of veterinary science. Gigi is a past President of the Society of Veterinary Hospital Pharmacists and of the American College of Veterinary Pharmacists. Ms. Davidson is the ACVP delegate to the American Pharmacists Association House of Delegates. Ms. Davidson was the Chair of the United States Pharmacopeia Compounding Expert Committee from 2010-2020 and continues to serve as a member. Gigi is the recipient of USP’s Beal Award when in 2015 she became the first female and first veterinary recipient of that award. She has many publications in peer-reviewed scientific journals, and her primary area of research interest is the stability, safety, and efficacy of compounded therapies in non-human species. Her research interests in retirement include drug disposition in honey bees and the pharmacological action of plant pollens and nectars on honey bee colonies.
Brenda Jensen CPhT, CNMT, MBA owns Compounding Consultants, LLC in Sioux Falls, SD. She has helped hundreds of compounding facilities across the country improve compounding quality and safety. Brenda is currently president-elect of the American College of Veterinary Pharmacists, serves on the Board of Directors for the American College of Apothecaries Research and Education Foundation, is a peer reviewer for Pharmacy Technician’s Letter, is a member of the APhA House of Delegates, and also teaches compounding courses for the American College of Apothecaries. She was previously the coordinator for the APhA Compounding Special Interest Group and served on the Board of Directors for the International Academy of Compounding Pharmacists and the Pharmacy Compounding Foundation. Brenda began volunteering for USP in 2013 and is currently Chair of the 2020–2025 Compounding Expert Committee.
Date: Wednesday, August 23, 2023 Time: 12:30 PM Eastern / 11:30 AM Central / 10:30 AM Mountain / 9:30 AM Pacific
Topic: What DEA Requires?
Host: Ernie Gates
Panelists: Carlos M. Aquino, an Associate with Gates Healthcare Associates, is an experienced consultant specializing in DEA compliance for pharmacies, hospitals, health clinics, medical practitioners, drug manufacturers and distributors.
Join us for a 1 hour webinar on ““Focus of a DEA Inspection on a Compounding Pharmacy (503A)”.
LEARNING OBJECTIVES Pharmacist – Describe role of DEA Diversion Control Division – Review how to prepare for a DEA inspection – Explain what are the DEA required records – Discuss the security of controlled substances – Identify the need for a Pharmacy Due Diligence Policy
Pharmacy Technician – Review the elements of a DEA inspection
– Explain what records are required to be readily available
– Recall the element of the evaluation of security for CS
– Identify what a pharmacist must know to prevent diversion of prescriptions for controlled substances
This meeting will not offer CE.
This meeting is open to all Pharmacy Professionals, FREE for ACA Members, $10 for non-members, registration is required.
In addition, members of the Compounding Faculty will have exclusive access to an online community.
Carlos M. Aquino, is President and Founder of PharmaDiversion, LLC and an Associate with Gates Healthcare Associates. A former DEA agent and supervisor, Carlos is an experienced consultant specializing in DEA compliance for pharmacies, hospitals, health clinics, medical practitioners, drug manufacturers and distributors.
Overview: One of the American College of Apothecaries’ strengths is the open sharing of ideas — which historically has been accomplished through in-person meetings. ACA is augmenting these meetings by establishing expert faculties that will assemble using digital technology — including Zoom, Microsoft Teams, email, and online forums. Participation in faculty meetings is intended to increase member engagement, thus facilitating peer-to-peer networking and relationship building.
Member in all classes: Faculty participation is optional and offered to ACA members at all individual membership levels, which include our Fellows, pharmacists, student pharmacists, pharmacy technicians, pharmacy marketers, and affiliates. Faculties will thus seasoned pharmacy professionals to interact and share their expertise and experiences with others who have high interest levels and are in the process of establishing their expertise. Each faculty will elect a Chair and Chair-Elect who will serve for one-year terms.
Meetings of faculty: Meetings of faculty will focus on topics about which members are passionate — and could include but not limited to discussions of specific products, techniques and methods, concepts, issues, and opportunities. Because meetings will not involve the awarding of continuing education credit, the discussions will not be restricted by ACPE guidelines. Hence, speakers at meetings of faculty could include representatives or organizations that provide proprietary items to our members.
Founding faculty sponsors: ACA is seeking financial support of organizations that are aligned with the expertise and interests of one or more of our faculties — and that desire to be designated “Founding Faculty Sponsor”.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.